Navigation Links
Montreal researchers prove that insulin-producing cells can give rise to stem-like cells in-vitro
Date:7/21/2008

Montreal, 17 July 2008 The question of whether insulin-producing cells of the pancreas can regenerate is key to our understanding of diabetes, and to the further development of regenerative therapies against the disease. Dr Rosenberg from the McGill University Health Centre (MUHC) and McGill University together with Dr Bernard Massie from the Centre hospitalier de l'Universit de Montral (CHUM) have just concluded that they can. The results of their study have been published in the July issue of the journal Laboratory Investigation.

The researchers have shown in vitro that insulin-producing β-cells (beta cells) can return to a more primitive developmental state called stem-like cells. This process is known as "dedifferentiation" and highlights the plasticity of this cell type. This same result has also been validated for the three additional types of cells that along with β-cells make up the islets of Langerhans. Together, these islet cells produce insulin and other hormones in the pancreas.

"The potential for dedifferentiation of all the different cells that make up the islets of Langerhans is a totally new finding," Dr. Rosenberg said.

"At this stage, we can't confirm whether the cells' ability to turn into stem-like cells occur naturally in a healthy pancreas, but the results are very encouraging for the development of regenerative therapies to fight diabetes," he continued. The cell's in-vitro plasticity opens up totally new avenues of investigation into the underlying causes of diabetes, and will validate the development of innovative treatments.

This study is the latest step in an extensive regenerative therapies research program based on a peptide called Islet Neogenesis Associated Protein, or INGAP. Dr. Rosenberg and his colleagues have demonstrated INGAP's potential to induce new islet formation in the pancreas. Clinical trials with INGAP have already demonstrated that it is possible to regrow new functional insulin-producing cells in diabetic patients.

"We know that the peptide works, but we are still lacking certain theoretical bases to explain its mechanism," said Dr. Rosenberg. "This finding will allow us to move ahead on firmer ground."


'/>"/>

Contact: Rebecca Burns
rebecca.burns@muhc.mcgill.ca
514-843-2189
McGill University Health Centre
Source:Eurekalert

Related medicine news :

1. The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
2. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
3. The Montreal Childrens Hospital of the MUHC begins search for causes of autism
4. Worrell Inc. Acquires Gad Shaanan Design Operations in Montreal and San Diego
5. World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress
6. Researchers Find Link Between Organ Transplants, Cancer
7. Tufts researchers discover link between DNA palindromes and disease
8. Researchers hone technique to KO pediatric brain tumors
9. Researchers link Huntingtons disease to overactive immune response in the brain
10. Researchers: Program discourages HIV transmission in Russia
11. Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... Multiple award ... been family-owned and operated for over 35 years. Maintaining core values of exceptional customer ... their success and made them a leading name in San Diego plumbing, and other ...
(Date:5/6/2016)... ... May 06, 2016 , ... Few events in healthcare changed ... for its cost despite its potential to wipe out a silent killer, hepatitis ... a class called direct-acting antivirals (DAAs)—have created fallout in the courts and state ...
(Date:5/6/2016)... ... May 06, 2016 , ... This Mother’s Day kicks off ... The 17th annual National Women’s Health Week takes place May 8-May 14. ... are combining forces to empower women to make their health a top priority. Women ...
(Date:5/6/2016)... ... 06, 2016 , ... “ Crossing Over: Affirmations of Faith in the Midst ... have allowed those holding vigil to glimpse into the supernatural as their lives ended. ... readers spiritually and practically gain insight into providing care to terminal patients. , ...
(Date:5/5/2016)... ... 2016 , ... TransWipe Volume 3 is a set of 30 professional transition ... preset between two video clips to instantly add a unique transition to any Final ... color and orientation options. TransWipe Volume 3 is a Final Cut Pro X exclusive ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... May 5, 2016  Endo International plc (NASDAQ: ... that Brian Lortie , President, U.S. Branded ... position upon the appointment of a successor. Mr. ... U.S. Pharmaceuticals business with responsibility for all strategic, ... strategy and portfolio development, commercial operations, managed markets, ...
(Date:5/5/2016)... First quarter 2016 adjusted diluted earnings per share (EPS) of ... First quarter reported diluted (GAAP) loss per share from continuing ... financial guidance; now expects 2016 revenues to range from $3.87 ... per share to range from $4.50 to $4.80 ... facility restructuring , Company expands Board capabilities, ...
(Date:5/5/2016)... , May 5, 2016  Diagnostic imaging ... decade due to concerns that these tests cause health ... approach to imaging, as well as the adoption ... era of medical peripherals that help health care providers cut ... Ampronix  advanced medical imaging is a renowned authorized reseller ...
Breaking Medicine Technology: